XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.22

-5.0%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: schadenfreude who wrote (8261)	1/12/1999 5:44:00 AM
From: Robert K.	Read Replies (2) of 17367

Otaku>Good point on the O.5 factor, however I didnt attempt the model, RobertS did.(big difference). Yes, we did address the approval/disapproval factors way back. Actually if you use that then you use 0.3 for a p2 and get 1.6 total expected however I expect the expected to change radically this year based on clinicals. All IMO btw-I think RobertS point was that if Neuprex gets approved in all those indications then its a $7 stock by his analysis. I dont agree with that at all.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next